drugset

drugset / Trial / NCT05345509

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

NCT05345509 ↗

Phase 1/2 Active not recruiting 62 enrolled Inventage Lab., Inc.

RandomizedSequentialOpen-labelTreatment

Summary

A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003

Timeline

Start: 2023-04-01
Primary completion: 2025-11-13
Completion: 2025-11-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	—	Oral

Indications